Mrinal M. Gounder

Also affiliated with Cornell University, Heidelberg University, University Hospital Heidelberg, Kettering University, Dana-Farber Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 33 papers. Top paper: “Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab”.

Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab

JAMA Oncology(2020)10.1001/jamaoncol.2019.6152

N/A

5.0DataRank · unranked

207 citations

Cristina R. Antonescu, Timothy G. Bowler, Rodrigo Ramella Munhoz, Ping Chi, Mark A. Dickson +21 more

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Nature Medicine(2017)10.1038/nm.4333

N/A

1.2DataRank · unranked

3490 citations

Ryma Benayed, Ronak H Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R. Kim +116 more

Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancers

Investigational New Drugs(2021)10.1007/s10637-020-01035-9

N/A

1.2DataRank · unranked

32 citations

D. Liu, Michael Offin, Cecilia Lezcano, Jean Torrisi, Sheldon L. Brownstein +13 more

Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets

Nature Communications(2022)10.1038/s41467-022-30453-x

N/A

0.808DataRank · unranked

218 citations

Francisco Sánchez-Vega, Shaleigh Smith, Cristina R. Antonescu, Evan Rosenbaum, Hongyu Shi +42 more

Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3909

N/A

0.627DataRank · unranked

16 citations

Li‐Xuan Qin, Niedzica Camacho, Ciara M. Kelly, Sandra P. D’Angelo, Mark A. Dickson +19 more

HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical Outcome

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0832

N/A

0.494DataRank · unranked

26 citations

Kenneth Seier, Chaitanya Bandlamudi, Mark A. Dickson, Mrinal M. Gounder, Mary Lou Keohan +12 more

Prospects for Epigenetic Targeted Therapies of Bone and Soft-Tissue Sarcomas

Sarcoma(2021)10.1155/2021/5575444

N/A

0DataRank · unranked

3 citations

Arielle Elkrief, Wei Guo, Neerav Shukla, Mrinal M. Gounder, Marc Ladanyi +1 more

Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma

Nature Communications(2022)10.1038/s41467-022-30496-0

N/A

0DataRank · unranked

194 citations

Narasimhan P. Agaram, Sally E. Trabucco, Victoria Robinson, Richard Ferraro, Sherri Z. Millis +38 more

Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004149

N/A

0DataRank · unranked

58 citations

Cristina R. Antonescu, Shaleigh Smith, Martina Bradić, Daniel Kashani, Allison L. Richards +17 more

The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms

Modern Pathology(2022)10.1038/s41379-022-01148-x

N/A

0DataRank · unranked

29 citations

Samuel Singer, William D. Tap, Benjamin A. Nacev, Ping Chi, Leonard H. Wexler +4 more

Sorafenib in Dupuytren and Ledderhose Disease

The Oncologist(2022)10.1093/oncolo/oyab050

N/A

0DataRank · unranked

3 citations

Narasimhan P. Agaram, Robert A. Lefkowitz, Ciara M. Kelly, John H. Healey, Mrinal M. Gounder +1 more

Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3135

N/A

0DataRank · unranked

0 citations

Yonina R. Murciano‐Goroff, Justin Jee, Maria E. Arcila, Darren J. Buonocore, Jianjiong Gao +15 more

A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3911

N/A

0DataRank · unranked

69 citations

Li‐Xuan Qin, Karissa Whiting, Allison L. Richards, Viswatej Avutu, Jason E. Chan +18 more

Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2378

N/A

0DataRank · unranked

36 citations

Mark A. Dickson, Mary E. Klein, Cristina R. Antonescu, Rodrigo Gularte‐Mérida, Marimar Benitez +31 more

Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

Cancer Research Communications(2023)10.1158/2767-9764.crc-22-0140

N/A

0DataRank · unranked

11 citations

Kenneth Seier, Martina Bradić, Ciara M. Kelly, Sujana Movva, Benjamin A. Nacev +12 more

PDGFRβ Signaling Cooperates with β-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type Fibromatosis

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2313

N/A

0DataRank · unranked

7 citations

Meera Hameed, Narasimhan P. Agaram, Karissa Whiting, Li‐Xuan Qin, Anthony M. Villano +12 more

A phase II study of palbociclib combined with retifanlimab in patients with advanced dedifferentiated liposarcoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps11590

N/A

0DataRank · unranked

3 citations

Evan Rosenbaum, Rodrigo Gularte Mérida, Mark A. Dickson, Mary Louise Keohan, Mrinal M. Gounder +15 more

Data from Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

(2023)10.1158/2767-9764.c.6886242.v1

N/A

0DataRank · unranked

0 citations

Kenneth Seier, Martina Bradić, Ciara M. Kelly, Sujana Movva, Benjamin A. Nacev +12 more

Data from Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

(2023)10.1158/2767-9764.c.6886242

N/A

0DataRank · unranked

0 citations

Kenneth Seier, Martina Bradić, Ciara M. Kelly, Sujana Movva, Benjamin A. Nacev +12 more

Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy

Cancer Discovery(2024)10.1158/2159-8290.cd-23-0110

N/A

0DataRank · unranked

45 citations

Daniel Cameron, Helen S. Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti +11 more

Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-2519

N/A

0DataRank · unranked

20 citations

Kenneth Seier, Viswatej Avutu, Lauren B. Banks, Jason E. Chan, Ping Chi +20 more

Data from Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma

(2024)10.1158/1078-0432.c.7077823.v1

N/A

0DataRank · unranked

0 citations

Mark A. Dickson, Mary E. Klein, Cristina R. Antonescu, Rodrigo Gularte‐Mérida, Marimar Benitez +31 more

1762P Utility of circulating tumor DNA (ctDNA) as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with treatment-naïve, advanced gastrointestinal stromal tumor (GIST)

Annals of Oncology(2024)10.1016/j.annonc.2024.08.1853

N/A

0DataRank · unranked

0 citations

Martina Bradić, Sara Saunds, V. Avutu, Jason W. Chan, Sandra P. D’Angelo +15 more

Milademetan in Advanced Solid Tumors with MDM2 Amplification and Wild-type TP53: Preclinical and Phase II Clinical Trial Results

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0762

N/A

0DataRank · unranked

11 citations

Thomas E. Stinchcombe, Mrinal M. Gounder, Gregory M. Coté, Glenn J. Hanna, Bradley Sumrall +16 more

Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas

Journal of Clinical Investigation(2025)10.1172/jci179282

N/A

0DataRank · unranked

5 citations

Helen S. Mueller, Daniel Cameron, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti +12 more

High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-012357

N/A

0DataRank · unranked

1 citations

Martina Bradić, Hyung Jun Woo, Allison L. Richards, Ciara M. Kelly, Mark A. Dickson +17 more

Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockade

npj Precision Oncology(2025)10.1038/s41698-025-00878-w

N/A

0DataRank · unranked

2 citations

Sara Coca Membribes, Cristina Anthonescu, Martina Bradić, Bernard O’Malley, Irina Linkov +9 more

Molecular profiling of sacral chordomas through methylation, spatial transcriptomics and multiplexed immunofluorescence

ESMO rare cancers.(2025)10.1016/j.esmorc.2025.100115

N/A

0DataRank · unranked

0 citations

George Jour, Gunjan Sinha, Jamal Benhamida, Nathaniel Aleynick, Hortense Le +11 more

Characterization of on-target adverse events caused by TRK inhibitor therapy

Annals of Oncology(2020)10.1016/j.annonc.2020.05.006

N/A

0DataRank · unranked

86 citations

James Flory, Andrew Lin, Michael Offin, Christina J. Falcon, Yonina R. Murciano‐Goroff +16 more

Genetic basis of SMARCB1 protein loss in 22 sinonasal carcinomas

Human Pathology(2020)10.1016/j.humpath.2020.08.004

N/A

0DataRank · unranked

28 citations

Paolo Cotzia, Ryan Ptashkin, Gouri J. Nanjangud, Bin Xu, Amir Momeni Boroujeni +7 more

Composite grading algorithm for National Cancer Institute’s PRO-CTCAE.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.7018

N/A

0DataRank · unranked

5 citations

Claus Becker, Lauren J. Rogak, Deborah Schrag, Bryce B. Reeve, Patricia A. Spears +15 more

Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities

Cancer(2021)10.1002/cncr.33618

N/A

0DataRank · unranked

229 citations

Anna Maria Frezza, Jean‐Yves Blay, Elizabeth H. Baldini, Sylvie Bonvalot, Judith V.M.G. Bovée +52 more

Checkpoint inhibitors and radiotherapy in refractory malignant melanocytic schwannoma with Carney complex: first evidence of efficacy

BMJ Case Reports(2021)10.1136/bcr-2020-240296

N/A

0DataRank · unranked

9 citations

Akhil Kapoor, Rakesh Jalali, Mrinal M. Gounder, Jyoti Bajpai